| Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. | |
| | |
MedLine Citation:
|
PMID: 21137114 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Current clinical research in eczema (atopic dermatitis) is hampered by a profusion of outcome measures, most of which have not been developed or tested adequately. The first Harmonising Outcome Measures for Eczema meeting (HOME 1) was an exploratory meeting to determine whether there was sufficient interest and enthusiasm in the international scientific community to form a collaborative group to define a minimum set of core outcomes for future eczema (atopic dermatitis) research. The meeting was open to all participants of the 6th Georg Rajka Symposium/International Symposium on Atopic Dermatitis/New Trends in Allergy VII meeting in Munich, 22-24 July 2010. Approximately 40 individuals attended. Prior to the meeting, an international Delphi exercise was performed to develop consensus-based sets of core outcome domains for eczema for 'controlled trials' and 'clinical recordkeeping'. The results of this Delphi exercise were presented at the meeting and critically discussed by the attendees. The constructive group discussion identified several important issues for future eczema outcomes research such as the degree to which patients and carers can be involved and the importance of involving colleagues from countries not represented at the meeting. In summary, this exploratory meeting indicated a genuine interest in the academic eczema community to form an international multiprofessional group dedicated to harmonizing outcomes research in eczema. The group decided to continue collaboratively with the HOME initiative. |
| | |
Authors:
|
J Schmitt; H Williams; |
Related Documents
:
|
21388504 - Abortion incidence and access to services in the united states, 2008. 21304724 - Meeting report: metagenomics, metadata and metaanalysis (m3) at ismb 2010. 16298954 - Charting a global future for education in physiology. 21300384 - Comparison of the scientific quality of spanish radiologists that publish in internatio... 7798604 - Lesbian identity and the politics of representation in betty parsons's gallery. 16049824 - Fens 2000--federation of european neuroscience societies. 24-28 june 2000, brighton, uk. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The British journal of dermatology Volume: 163 ISSN: 1365-2133 ISO Abbreviation: Br. J. Dermatol. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-06 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0004041 Medline TA: Br J Dermatol Country: England |
Other Details:
|
Languages: eng Pagination: 1166-8 Citation Subset: IM |
Affiliation:
|
Universitäts AllergieCentrum, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany. jochen.schmitt@uniklinikum-dresden.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Investigator | |
Investigator/Affiliation:
|
Christian Apfelbacher / ; Mark Boguniewicz / ; Johnson Cornelius / ; Joanne Chalmers / ; Ulf Darsow / ; Magdalene Dohil / ; Thomas Diepgen / ; Douglas De Boer / ; Carsten Flohr / ; Masutaka Furue / ; Toshiharu Fujiyama / ; Uwe Gieler / ; Jon Hanifin / ; Hideo Hashizume / ; Inge Haeck / ; Yoko Kataoka / ; Laura von Kobyletzki / ; Michael Meurer / ; Ralf Mueller / ; F Mastrandrea / ; Helen Nankervis / ; Stevan Naidoo / ; Yukihiro Ohya / ; Thierry Olivry / ; Peter Schmid-Grendelmeier / ; Phyllis Spuls / ; Ake Svensson / ; Mandy Schram / ; Jochen Schmitt / ; Eric Simpson / ; Kim Thomas / ; Satoshi Takeuchi / ; Annika Volke / ; Andreas Wollenberg / ; Stephan Weidinger / ; Hywel Williams / ; Gil Yosipovitch / |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multiple desmoplastic cellular neurothekeomas localized to the face of a 16-year-old boy.
Next Document: A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms.